ID: ALA4763184

Max Phase: Preclinical

Molecular Formula: C8H15NO

Molecular Weight: 141.21

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCN1CC=CC(O)C1

Standard InChI:  InChI=1S/C8H15NO/c1-2-5-9-6-3-4-8(10)7-9/h3-4,8,10H,2,5-7H2,1H3

Standard InChI Key:  SCQGIHOWTNYUJH-UHFFFAOYSA-N

Associated Targets(non-human)

Choline trimethylamine-lyase 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 141.21Molecular Weight (Monoisotopic): 141.1154AlogP: 0.63#Rotatable Bonds: 2
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.16CX LogP: 0.79CX LogD: -0.96
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.57Np Likeness Score: 0.54

References

1. Bollenbach M,Ortega M,Orman M,Drennan CL,Balskus EP.  (2020)  Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.,  11  (10): [PMID:33062182] [10.1021/acsmedchemlett.0c00005]

Source